Janux Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.

About JANX

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.

CEO

David Campbell

CEODavid Campbell

Employees

Employees64

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2017

Founded2017

Employees

Employees64

JANX Key Statistics

Market cap

2.51B

Market cap2.51B

Price-Earnings ratio

-36.41

Price-Earnings ratio-36.41

Dividend yield

—

Dividend yield—

Average volume

1.14M

Average volume1.14M

High today

$49.13

High today$49.13

Low today

$47.66

Low today$47.66

Open price

$48.14

Open price$48.14

Volume

20.92K

Volume20.92K

52 Week high

$58.69

52 Week high$58.69

52 Week low

$5.65

52 Week low$5.65

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

Janux Therapeutics

Why Robinhood?

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA. Show more

JANX Key Statistics

Analyst ratings

100%

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.